Doyle Ramona
Insider CIK 1856069 · RXRX Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2022-05-16 | 2022-05-18 | 832 | $5.67 | $4.7K | 121,110 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2022-03-31 | 2022-04-04 | 9,072 | — | $0 | 669,356 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2022-03-31 | 2022-04-04 | 9,072 | $2.48 | $22.5K | 121,942 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2022-02-28 | 2022-03-01 | 15,625 | — | $0 | 678,428 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2022-02-28 | 2022-03-01 | 15,625 | $2.48 | $38.8K | 112,870 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2022-02-04 | 2022-02-08 | 4,784 | — | $0 | 4,784 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award deriv | 2022-02-04 | 2022-02-08 | 76,998 | — | $0 | 76,998 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2022-02-04 | 2022-02-08 | 38,499 | — | $0 | 95,834 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | F Tax w/h | 2022-02-04 | 2022-02-08 | 981 | $11.40 | $11.2K | 97,245 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | A Award | 2022-02-04 | 2022-02-08 | 2,392 | — | $0 | 98,226 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2022-01-31 | 2022-02-02 | 15,625 | — | $0 | 694,053 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2022-01-31 | 2022-02-02 | 15,625 | $2.48 | $38.8K | 57,335 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise deriv | 2022-01-03 | 2022-01-05 | 40,322 | — | $0 | 709,678 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | M Exercise | 2022-01-03 | 2022-01-05 | 40,322 | $2.47 | $99.6K | 40,322 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 750,000 | — | $0 | 0 | SEC↗ |
| RXRX RECURSION PHARMACEUTICALS, | C Conversion deriv | 2021-04-20 | 2021-04-22 | 750,000 | — | $0 | 750,000 | SEC↗ |